Nitromed Inc (NTMD)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
12 OAK PARK DR BEDFORD, MA 01730

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Discovers, develops and seeks to commercialize proprietary pharmaceuticals. This emerging pharmaceutical company (Mar. 31, 2005) is developing its lead nitric oxide-enhancing drug candidate, BiDil, to treat African Americans diagnosed with heart failure.

Data derived from most recent annual or quarterly report
Market Cap 39.212 Million Shares Outstanding46.077 Million Avg 30-day Volume 147.465 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 0.0 / Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million
View SEC Filings from NTMD instead.

View recent insider trading info

Funds Holding NTMD (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NTMD BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

RHO VENTURES IV QP LP

RHO VENTURES IV GMBH & CO BETEILIGUNGS KG

RHO CAPITAL PARTNERS VERWALTUNGS GMBH

RHO MANAGEMENT TRUST II

RHO VENTURES IV LP

RHO CAPITAL PARTNERS INC

RUCH JOSHUA

KAIROUZ HABIB

RHO MANAGEMENT VENTURES IV LLC

  • 10% Owner
No longer subject to file 2009-04-24 0

FLYNN JAMES E

DEERFIELD CAPITAL LP

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD MANAGEMENT CO /NY

DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LTD

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
46,085,133 2009-04-24 0

LITTLECHILD JOHN W

  • Director
No longer subject to file 2009-04-24 0

RHO INVESTMENT PARTNERS H LP

ATLAS CAPITAL CORP

RHO MANAGEMENT PARTNERS L P

  • 10% Owner
No longer subject to file 2009-04-24 0

HOROVITZ ZOLA P

  • Director
No longer subject to file 2009-04-24 0

INVUS PUBLIC EQUITIES ADVISORS, LLC

INVUS PUBLIC EQUITIES, LP

ULYS, LLC

DEBBANE RAYMOND

  • 10% Owner
No longer subject to file 2009-04-24 0

SOBECKI CHRISTOPHER J

  • Director
No longer subject to file 2009-04-24 0

LESCHLY MARK

  • Director
  • 10% Owner
No longer subject to file 2009-04-24 0

KARABELAS ARGERIS N

  • Director
No longer subject to file 2009-04-24 0

BATE KENNETH PRESIDENT & CEO

  • Officer
  • Director
No longer subject to file 2009-04-24 0

COHEN ROBERT S

  • Director
No longer subject to file 2009-04-24 0

SCOON DAVEY

  • Director
No longer subject to file 2009-04-24 0

LOSCALZO JOSEPH

  • Director
No longer subject to file 2009-04-24 0

DOUGLAS FRANK L

  • Director
No longer subject to file 2009-04-24 0

SARNEY KEVIN G CONTROLLER

  • Officer
No longer subject to file 2009-04-24 0

DEERFIELD PRIVATE DESIGAN FUND L P

DEERFIELD PRIVATE DESIGN INTERNATIONAL, L.P.

NTMD PARENT ACQUISITION CORP.

NTMD ACQUISITION CORP.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
0 2009-01-27 0

KRAMER JANE VICE PRESIDENT

  • Officer
37,051 2008-04-15 0

HAM JAMES G III VP AND CFO

  • Officer
47,363 2008-03-16 0

BRUCE GERALD W SENIOR VICE PRESIDENT

  • Officer
46,072 2008-03-15 0

WORCEL MANUEL CHIEF MEDICAL OFFICER

  • Officer
252,896 2008-01-16 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments